• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Novartis

Novartis

Novartis AG ADR NVS 3 Star

Last Price$101.00Day Change (%)0.62%
Open Price$100.38Day Change ($)0.62
Day Range100.34–101.1752-Week Range81.42–103.50

As of Mon 3/30/2015 11:46:00 AM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Novartis Gets EU Approval for Jakavi Rare Blood Cancer Drug

    Novartis Gets EU Approval for Jakavi Rare Blood Cancer Drug

  2. Aduro Biotech Establishes Major Collaboration with Novartis for Global Research, Development and Commercialization of Immuno-Oncology Products Derived from its Proprietary STING-Targeted CDN Platform ...

    Aduro Biotech Establishes Major Collaboration with Novartis for Global Research, Development and Commercialization of Immuno-Oncology Products Derived from its Proprietary STING-Targeted CDN Platform Technology

  3. UPDATE: First-ever bio-generic drug doesn't help Novartis shares

    UPDATE: First-ever bio-generic drug doesn't help Novartis shares

  4. Judge Denies Amgen's Request to Block Novartis's Biosimilar of Neupogen

    Judge Denies Amgen's Request to Block Novartis's Biosimilar of Neupogen

  5. Research and Markets: Global HER-2 Positive Breast Cancer Market 2015-2019 with Celgene, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Sanofi Dominating

    Research and Markets: Global HER-2 Positive Breast Cancer Market 2015-2019 with Celgene, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis & Sanofi Dominating

  6. PG&E Appoints Julie M. Kane to New Position as Senior Vice President and Chief Ethics and Compliance Officer; Company Takes Next Step Toward Goal of Establishing a Best-in-Class Corporate Ethics ...

    PG&E Appoints Julie M. Kane to New Position as Senior Vice President and Chief Ethics and Compliance Officer; Company Takes Next Step Toward Goal of Establishing a Best-in-Class Corporate Ethics Program

  7. Research and Markets: QLT PhotoTherapeutics and Novartis Pharma AG's Visudyne (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

    Research and Markets: QLT PhotoTherapeutics and Novartis Pharma AG's Visudyne (Macular Edema and Macular Degeneration) - Forecast and Market Analysis to 2023

  8. ADR Shares End Mixed; BHP Billiton Shares Rise

    ADR Shares End Mixed; BHP Billiton Shares Rise

  9. GSK Raises $854 Million From Aspen Pharmacare Share Sale

    GSK Raises $854 Million From Aspen Pharmacare Share Sale

  10. GSK Raises $854 Million from Aspen Share Sale

    GSK Raises $854 Million from Aspen Share Sale

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.